Infinity Pharmaceuticals, Inc.
(NASDAQ GS: INFI)
Rigrodsky Law, P.A. is investigating Infinity Pharmaceuticals, Inc. (“Infinity”) regarding possible breaches of fiduciary duties and other violations of law related to Infinity’s agreement to merge with MEI Pharma, Inc.